CNBC's Jim Cramer pointed to Lockheed Martin's 31% surge over the past year as a standout defense play, suggesting the aerospace giant may have more room to run amid heightened global tensions and robust government spending.
CNBC's Jim Cramer highlighted Lam Research (LRCX) as a top January performer in the S&P 500, recommending investors build a position in the chip equipment maker gradually to manage risk amid sector volatility.
CNBC's Jim Cramer acknowledged Moderna's strong January performance but expressed caution, noting the company faces years of unprofitability and highlighting other pharmaceutical and biotech stocks he finds more attractive for investment.
CNBC's Jim Cramer offered a tempered critique of Microsoft following its latest earnings call, labeling it the 'least magnificent' of the tech titans. While expressing a degree of sympathy for the company, his comments underscore broader investor scrutiny over its growth narrative amid complex quarterly results.
While Nordson Corporation may not be chasing explosive growth, its consistent 14% return on capital employed and disciplined reinvestment strategy have delivered solid, long-term value for shareholders. We analyze the stability behind the industrial technology leader's performance.
Alvotech (ALVO), a fast-growing biosimilars manufacturer, is showing explosive revenue growth and a sharp pivot to profitability. Yet its stock languishes near 52-week lows, creating a stark valuation disconnect that has caught the attention of value investors.
Amidst streaming wars and a skeptical Wall Street, SiriusXM Holdings Inc. (SIRI) presents a compelling investment thesis built on resilient cash flows, upgraded guidance, and a loyal subscriber base. We analyze the numbers and the narrative.
CNBC's Jim Cramer has singled out Constellation Energy (CEG) as a compelling buy following its significant pullback, emphasizing its position as a major nuclear power producer and its current valuation opportunity.
Driven by blockbuster sales of its weight-loss and diabetes treatments, Eli Lilly's 2025 revenue surged 45%, with the company forecasting even stronger growth for 2026 as it prepares to launch a pivotal oral therapy.
David Flueck, the executive credited with shaping the Marriott Bonvoy program, will retire at month's end. His departure is part of a broader wave of senior leadership changes at the hospitality giant, following a recent corporate restructuring.
The U.S. Supreme Court has declined to intervene, allowing California's newly drawn congressional districts—expected to favor Democrats in five seats—to stand for the 2026 midterms. The decision follows state voters' approval of Proposition 50 and marks a setback for Republican efforts alleging racial gerrymandering.
White House border advisor Tom Homan sharply criticized and dismissed anti-ICE roadblocks in Minneapolis as ineffective and illegal, while announcing the withdrawal of 700 federal agents from the Twin Cities area following what he described as improved local cooperation.
A doorbell camera video of a delivery driver refusing to hand over a pizza without a tip during a severe winter storm has ignited fierce online debate about service worker compensation and etiquette in extreme conditions.
As stablecoin capitalization surges past $300 billion, a new Moody's report warns that structural vulnerabilities, including opaque reserves and weak governance, could undermine the perceived stability of these digital assets and pose systemic risks.
BetMGM announced record financial results for fiscal year 2025, with net revenue soaring 33% to $2.8 billion. While CEO Adam Greenblatt reaffirmed the company's iGaming focus, a 63% surge in online sports betting revenue proved the primary growth driver, signaling a pivotal shift in the competitive U.S. digital gaming landscape.
As corporate mandates for full-time office work intensify, a growing body of evidence suggests the push may be backfiring, with the most skilled employees and working parents most likely to walk out the door.
Shares of cloud communications provider 8x8 soared more than 50% Wednesday after the company reported quarterly results that exceeded expectations and issued guidance well above analyst forecasts, signaling a potential turnaround.
A proposed acquisition of eye-lens maker STAAR Surgical by Alcon faces fierce resistance from major investors, who argue the company is being sold at a cyclical low. The clash has forced deal amendments and delays, setting the stage for a potential proxy fight or higher bid.
Amid a prolonged freight recession, TFI International's stock has been battered. Yet, a deep dive into its fundamentals reveals a resilient cash-generating machine poised to capitalize on an impending industry-wide capacity shock, setting the stage for a potential major rerating.
As Tesla's stock navigates volatile valuations, a growing chorus of investors is betting the company's future lies not just in electric vehicles, but in its emerging high-margin businesses and a pipeline of ambitious projects set to redefine its revenue base by the end of the decade.
